| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Here's a look at the Q3 earnings report from United States Antimony.
United States Antimony (AMEX:UAMY) sees FY2025 sales of $40.000 million-$43.000 million vs $46.389 million analyst estimate.
United States Antimony (AMEX:UAMY) sees FY2026 sales of $125.000 million vs $109.450 million analyst estimate.
United States Antimony (AMEX:UAMY) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate o...
United States Antimony Corporation ("USAC," "US Antimony," the "Company"), (NYSE:UAMY)(NYSE Texas:UAMY)...